BMT_GVHD_DRUGS

Description: |
The list of drugs to be used for graft vs. host disease (GVHD) prophylaxis.

Primary Key

Column Name | Ordinal Position |
--- | --- | ---
REGIMEN_ID | 1 |
CONTACT_DATE_REAL | 2 |
LINE | 3 |

Column Information

| Name | Type | Discontinued? |
--- | --- | --- | --- | ---
1 | REGIMEN_ID | NUMERIC | No |
The unique identifier for the blood and marrow transplant treatment regimen.
2 | CONTACT_DATE_REAL | FLOAT | No |
A unique contact date in decimal format. The integer portion of the number indicates the date of contact. The digits after the decimal distinguish different contacts on the same date and are unique for each contact on that date. For example, .00 is the first/only contact, .01 is the second contact, etc.
3 | LINE | INTEGER | No |
The line number for the information associated with this contact. Multiple pieces of information can be associated with this contact.
4 | CONTACT_DT | DATETIME | No |
The date of this contact in calendar format.
5 | GVHD_DRUG_C_NAME | VARCHAR | No |
The graft versus host disease drugs to use
May contain organization-specific values: Yes
Category Entries:
Tacrolimus (FK 506)
Cyclosporine (CSA, Neoral, Sandimmune)
Mycophenolate mofetil (MMF) (CellCept)
Sirolimus (Rapamycin, Rapamune)
Methotrexate (MTX) (Amethopterin)
ALG/ALS/ATG/ATS
Extra-corporeal photopheresis (ECP)
Etanercept
Alemtuzumab
In vivo immunotoxin
Infliximab
Cyclophosphamide (Cytoxan)
Anti CD 25 (Zenapax, Daclizumab, AntiTAC)
Other agent
In vivo monoclonal antibody
Blinded randomized trial
Corticosteroids (systemic)
Everolimus
Abatacept
Bortezomib
CD34 enriched (CD34+ selection)
Ex-vivo T-cell depletion
Filgotinib
Maraviroc
Ruxolitinib
Tocilizumab